You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 254 No. 21, December 6, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  PRELIMINARY COMMUNICATION
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Muscarinic Acetylcholine Receptors in Alzheimer's Disease

In Vivo Imaging With Iodine 123—Labeled 3-Quinuclidinyl-4-Iodobenzilate and Emission Tomography

B. Leonard Holman, MD; Raymond E. Gibson, PhD; Thomas C. Hill, MD; William C. Eckelman, PhD; Marilyn Albert, PhD; Richard C. Reba, MD

JAMA. 1985;254(21):3063-3066.


Abstract

In vivo imaging of muscarinic acetylcholine receptor binding function in a patient with Alzheimer's disease, using single-photon emission computed tomography and iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate (123I-QNB), and perfusion imaging using123I-N-isopropyl p-iodoamphetamine are described. A profound decrease in perfusion to the posterior temporal and parietal cortex and a more uniform uptake of123I-QNB throughout the cerebral cortex were observed. The123I-QNB activity ratio was reduced compared with that of a normal age-matched subject, suggesting a moderate impairment in muscarinic receptor binding function in Alzheimer's disease. Furthermore, and more importantly, our study demonstrates that images of in vivo receptor binding can be obtained easily and nontraumatically using123I-QNB and single-photon emission computed tomography.

(JAMA 1985;254:3063-3066)



Author Affiliations

From the Departments of Radiology, Harvard Medical School, Brigham and Women's Hospital and New England Deaconess Hospital, Boston (Drs Holman and Hill); the Department of Radiology, George Washington University Medical Center, Washington, DC (Drs Gibson, Eckelman, and Reba); the Departments of Psychiatry and Neurology, Massachusetts General Hospital, Boston (Dr Albert); and the Division of Aging (Dr Albert), Harvard Medical School, Boston.


Footnotes

Reprint requests to Department of Radiology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115 (Dr Holman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Molecular Neuroimaging: From Conventional to Emerging Techniques
Hammoud et al.
Radiology 2007;245:21-42.
ABSTRACT | FULL TEXT  

New Approaches for Determining the Site of Salivary Fluid Secretory Disorders
Baum et al.
ADR 1993;7:220-224.
ABSTRACT  

The Distribution of Cerebral Muscarinic Acetylcholine Receptors In Vivo in Patients With Dementia: A Controlled Study With 123IQNB and Single Photon Emission Computed Tomography
Weinberger et al.
Arch Neurol 1991;48:169-176.
ABSTRACT  

Single-Photon Emission Computed Tomography (SPECT) Applications and Potential
Holman and Tumeh
JAMA 1990;263:561-564.
ABSTRACT  

Research in Alzheimer's disease: A progress report
Moss
AM J ALZHEIMERS DIS OTHER DEMEN 1988;3:10-16.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.